These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32742441)

  • 1. The prognostic value of COL3A1/FBN1/COL5A2/SPARC-mir-29a-3p-H19 associated ceRNA network in Gastric Cancer through bioinformatic exploration.
    Shen H; Wang L; Chen Q; Xu J; Zhang J; Fang L; Wang J; Fan W
    J Cancer; 2020; 11(17):4933-4946. PubMed ID: 32742441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
    Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of H19/miR-29a-3p/COL1A1 axis in COE-induced lung cancer.
    Zhang H; Li X; Jia M; Ji J; Wu Z; Chen X; Yu D; Zheng Y; Zhao Y
    Environ Pollut; 2022 Nov; 313():120194. PubMed ID: 36150622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Li J; Wang X; Wang Y; Yang Q
    Epigenomics; 2020 Jun; 12(12):989-1002. PubMed ID: 32432496
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
    Li S; Liu X; Li H; Pan H; Acharya A; Deng Y; Yu Y; Haak R; Schmidt J; Schmalz G; Ziebolz D
    J Periodontal Res; 2018 Aug; 53(4):495-505. PubMed ID: 29516510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer.
    Arun K; Arunkumar G; Bennet D; Chandramohan SM; Murugan AK; Munirajan AK
    Oncotarget; 2018 Apr; 9(26):18386-18399. PubMed ID: 29719612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without
    Chu A; Liu J; Yuan Y; Gong Y
    J Cancer; 2019; 10(4):853-863. PubMed ID: 30854091
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis.
    Liu J; Sun Y; Zhu B; Lin Y; Lin K; Sun Y; Yao Z; Yuan L
    Life Sci; 2021 Jul; 277():119455. PubMed ID: 33831428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 network as a prognostic biomarker in gastric cancer.
    Li P; Ji W; Wei Z; Wang X; Qiao G; Gao C; Wang Y; Qi F
    Hereditas; 2022 Nov; 159(1):43. PubMed ID: 36447214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer.
    Zheng X; Wang X; Zheng L; Zhao H; Li W; Wang B; Xue L; Tian Y; Xie Y
    Front Pharmacol; 2020; 11():1112. PubMed ID: 32848739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure.
    Zheng Y; Zhang Y; Zhang X; Dang Y; Cheng Y; Hua W; Teng M; Wang S; Lu X
    Front Cardiovasc Med; 2021; 8():747449. PubMed ID: 34692796
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.
    Huang M; Zhong Z; Lv M; Shu J; Tian Q; Chen J
    Oncotarget; 2016 Jul; 7(30):47186-47200. PubMed ID: 27363013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
    He H; Wang N; Yi X; Tang C; Wang D
    Cell Biosci; 2017; 7():65. PubMed ID: 29214011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer.
    Zhang S; Xiang X; Liu L; Yang H; Cen D; Tang G
    Cancer Manag Res; 2021; 13():8929-8951. PubMed ID: 34876855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.